Preparation of Natural Compounds-tripeptides Derivatives and Their Melanogensis Inhibitory Activity
![]() |
Shin, Kyong-Hoon
(Central Research, Aekyung R&D Center)
Lee, Jae-Ho (Structural Biology Lab., Gwangju Institute of Science and Technology) Ryu, Geun-Seok (Central Research, Aekyung R&D Center) Jee, Kyung-Yup (Central Research, Aekyung R&D Center) Park, Soo-Nam (Research Center for Development of Green Cosmetic, Seoul National University of Science and Technology) Kim, Jae-Il (Structural Biology Lab., Gwangju Institute of Science and Technology) Cho, In-Shik (Central Research, Aekyung R&D Center) Kim, Han-Young (Central Research, Aekyung R&D Center) |
1 | T. K. von Almen, G. A. Olson, and R. D. Olson, Behavioral effects of melanocyte stimulating hormone release-inhibiting factor-1, Neuroscience & Biobehavioral Reviews, 7(2), 257 (1983). DOI ScienceOn |
2 | D. Kim, S. Park, S. Kwon, K. Li, S. Youn, and K. Park, (-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production, Arch. Pharm. Res., 27(3), 334 (2004). 과학기술학회마을 DOI ScienceOn |
3 | K. Ohguchi, C. Nakajima, M. Oyama, M. Iinuma, T. Itoh, Y. Akao, Y. Nozawa, and M. Ito, Inhibitory effects of flavonoid glycosides isolated from the peel of Japanese Persimmon (Diospyros kaki 'Fuyu') on melanin biosynthesis, Biol. Pharm. Bull., 33(1), 122 (2010). DOI ScienceOn |
4 | K. Schallreuter, A. Slominski, J. M. Pawelek, K. Jimbow, and B. A. Gilchrest, What controls melanogenesis?, Exp. Dermatol., 7, 143 (1998). DOI ScienceOn |
5 | L. H. Brinckerhoff, V. V. Kalashnikov, L. Thompson, G. V. Yamshchikov, R. A. Pierce, H. S. Galavotti, V. H. Engelgard, and C. L. Slingluff, Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines, Int. J. Cancer, 83, 326 (1999). DOI ScienceOn |
6 | A. Perez-Bernal, M. A. Munoz-perez, and F. Camacho, Management of facial hyperpigmentation, Am. J. Clin. Dermatol., 1(5), 261 (2000). DOI ScienceOn |
7 | Y. J. Kima and H. Uyamab, Tyrosinase inhibitors from natural and synthetic sources:structure, inhibition mechanism and perspective for the future, Cell. Mol. Life Sci., 62, 1707 (2005). DOI ScienceOn |
8 | S. Parvez, M. Kang, H. Chung, C. Cho, M. Hong, M. Shin, and H. Bae, Survey and mechanism of skin depigmenting and lightening agents, Phytother. Res., 20, 921 (2006). DOI ScienceOn |
9 | S. Boonanuntanasarn, G. Yoshizaki, and T. Takeuchi, Specific gene silencing using small interfering RNAs in fish embryos. Biochem. Biophys. Res. Commun., 310, 1089 (2003). DOI ScienceOn |
10 | J. W. Wiechers, A. V. Rawlings, C. Garcia, C. Chesne, P. Balaguer, J. C. Nicolas, S. Corre, and M.-D. Galibert, A new mechanism of action for skin whitening agents: binding to the peroxisome proliferator activated receptor, Int. J. Cosmetic Sci., 27, 123 (2005). DOI ScienceOn |
11 | A. M. Lopez-Contreras, J. H. Martinez-Liarte, F. Solano, P. Samaraweera, J. M. Newton, and J. T. Bagnara, The amphibian melanization inhibiting factor (MIF) blocks the alpha-MSH effect on mouse malignant melanocytes, Pigment Cell Res., 9(6), 311 (1996). DOI ScienceOn |
12 | S. Bonettoa, I. Carlavan, and D. Baty, Isolation and agonist peptides to the human melanocortin 1 receptor, Peptides, 26, 2302 (2005). DOI ScienceOn |
13 | C. Haskell-Luevano, J. R. Holder, E. K. Monck, and R. M. Bauzo, Characterization of melanocortin NDPMSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors, J. Med. Chem., 44, 2247 (2001). DOI ScienceOn |
14 | M. Tsatmali, J. Ancans, and A. J. Thody, Melanocyte function and its control by melanocortin peptides, J. Histochem. Cytochem., 50(2), 125 (2002). DOI ScienceOn |
15 | K. V. Bossche, J. Naeyaert, and J. Lambert, The quest for the mechanism of melanin transfer, Traffic, 7(7), 769 (2006). DOI ScienceOn |
16 | R. E. Boissy, Melanosome transfer to and translocation in the keratinocyte, Experimental Dermatology, 12, 5 (2003). DOI ScienceOn |
17 | WO2007137015A2, Dermatological uses of tri-, tetra-, penta-, and polypeptides |
18 | K. Sato, H. Takahashi, R. Iraha, and M. Toriyama, Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma, Biol. Pharm. Bull., 31(1), 33(2008). DOI ScienceOn |
19 | J. Koo, H. T. Kim, H. Yoon, K. Kwon, I. Choi, S. H. Jung, H. Kim, B. Park, and J. Park, Effect of xanthohumol on melanogenesis in B16 melanoma cell, Exp. Mol. Medicine, 40(3), 313 (2008). DOI ScienceOn |
20 | K. Sato and M. Toriyama, Depigmenting Effect of Catechins, Molecules, 14, 4425 (2009). DOI ScienceOn |
21 | A. Andrawis and V. Kahn, Effect of methimazole on the activity of mushroom tyrosinase, Biochem. J., 235, 91 (1986). DOI |
22 | H. Kim, J. Choi, J. K. Cho, S. Y. Kim, and Y. S. Lee, Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity, Bioorganic & Medicinal Chemistry Letters, 14, 2843 (2004). DOI ScienceOn |
23 | D. S. King, C. G. Fields, and G. B. Fields, A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis, Int. J. Pept. Protein Res., 36, 255 (1990). |
24 | E. Kaiser, R. L. Colescott, C. D. Bossinger, and P. Cook, Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides, Anal. Biochem. 34, 595 (1970). DOI ScienceOn |
25 | Synthetic Peptides: A User's Guide (G.A. Grant, ed.), W. H. Freeman and Company, New York, (1992). |
26 | M. F. Powell, T. Stewart, L. Otvos, L. Urge, F. C.A. Gaeta, A. Sette, T. Arrhenius, D. Thomson, K. Soda, and S. M. Colon, Peptide stability in drug development. II. Effects of single amino acid substitution and glycosylation on peptide reactivity in human serum, Pharm. Res., 10, 1268 (1993). DOI ScienceOn |
27 | D. I. Jang, B. G. Lee, C. O. Jeon, N. S. Jo, and J. S. Koh, Melanogenesis inhibitor from paper mulberry, Cosmet. Toiletries, 112(3), 59 (1997). |
![]() |